Privado Health Partners: Transforming Healthcare Together

Partnerships with Urologists

Urologists are often the first to know about a prostate cancer diagnosis and can help create treatment plans and guidance for prostate cancer patients. There are many options for patients at all cancer stages that have less-than-ideal side effects. Theranostics will provide an expanded patient choice and could improve outcomes for many qualified candidates. Urologists can refer patients to Privado and/or treatment within urology clinics is also an option

Urologist Partnership

Our goal (like yours) is to prolong the lifespan of cancer patients while improving their quality of life during and after treatment. We provide you with another arrow in your quiver to do just that. For qualified patients, theranostics might be part of the ideal treatment plan. Privado Health partners with oncologists to develop a reliable workflow for those qualified patients and will assist you as theranostics expands into other types of cancer beyond prostate and neuroendocrine tumors.

Learn More

Partnerships with Oncologists

Partnerships with Radiation Oncology Centers

Privado has a proven track record in managing safety protocols and the tricky logistics of administering theranostics treatments to multiple patients per day. The opportunity to bring this groundbreaking treatment procedure to as many patients that need it, will be done by Privado partnering with oncology centers like yours.

Radiation Oncology Center Partnerships

Clinical Trial
Partnerships

Privado Health is committed to being at the forefront of cancer treatment using Theranostics. Dr Frankis Almaguel, is a leader in his field of Nuclear Oncology and Molecular Imaging, he has been deeply involved in the research surrounding cancer treatments using theranostics. Dr. Almaguel continues to successfully perform clinical trials across many different types of cancer. We are uniquely positioned to participate in other theranostics clinical trials to advance the efficacy and relative safety of theranostics in the future.

Clinical Trial Partnerships

We are the experts in using Theranostics to fight Cancer more intelligently.

Meet our Medical Director, Dr. Frankis Almaguel, MD, PhD, an unparalleled expert in Theranostics with a unique blend of extensive research and hands-on patient care knowledge.

Nuclear Oncologist at Loma Linda University Cancer Center

Leads the Molecular Imaging & Therapeutics Program at Loma Linda

Specializes in Prostate Cancer & Nuclear Oncology

Has been the lead researcher for numerous Clinical Trials for Theranostics in Prostate Cancer, Breast Cancer and 26 other cancer types

Has treated more patients with Theranostics than any other provider in the world

Erase Cancer

Alan Held Erased His Cancer With Theranostics

Alan Held underwent a groundbreaking theranostics treatment for prostate cancer in Germany. This innovative approach, led by Dr. Frankis Almaguel at Loma Linda University Medical Center, eradicated 80% of Held’s cancer cells after just one session. With thousands benefiting from theranostics in Germany, the FDA has now approved Theranostics for use in the U.S., signaling a transformative shift in prostate cancer care. The before and after shows Mr. Held’s results from treatment with Theranostics.